E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 2/7/2014 in the Prospect News PIPE Daily.

Semler to price its IPO of 1.18 million shares between $7.50 and $9.50

Aegis assists; proceeds used for working capital, corporate purposes

By Devika Patel

Knoxville, Tenn., Feb. 7 - Semler Scientific, Inc. will sell 1.18 million common shares in its firm commitment initial public offering with a 45-day greenshoe of 177,000 additional shares, according to a Form S-1/A filed Friday with the Securities and Exchange Commission. The deal was announced Nov. 15.

The stock will be sold at a price expected to fall between $7.50 and $9.50 per share.

Aegis Capital Corp. is the sole bookrunning manager.

Proceeds will be used for working capital and general corporate purposes.

The medical risk-assessment company is based in Portland, Ore. The company expects its shares will trade on the Nasdaq under the symbol "SMLR."


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.